BIOCRYST PHARMACEUTICALS INC's ticker is BCRX and the CUSIP is 09058V103. A total of 137 filers reported holding BIOCRYST PHARMACEUTICALS INC in Q1 2020. The put-call ratio across all filers is 0.14 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $171,053 | +14.8% | 24,160 | +71.6% | 0.16% | +136.8% |
| Q2 2022 | $149,000 | -7.5% | 14,081 | +38.1% | 0.07% | -52.1% |
| Q2 2021 | $161,000 | +323.7% | 10,195 | -7.2% | 0.14% | +610.0% |
| Q4 2019 | $38,000 | +22.6% | 10,989 | 0.0% | 0.02% | +100.0% |
| Q3 2019 | $31,000 | -27.9% | 10,989 | -3.5% | 0.01% | -37.5% |
| Q2 2019 | $43,000 | – | 11,389 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DG Capital Management, LLC | 1,186,726 | $4,076,000 | 2.45% |
| Sarissa Capital Management LP | 4,861,000 | $16,697,000 | 1.97% |
| Ghost Tree Capital, LLC | 1,950,000 | $6,698,000 | 1.94% |
| ORACLE INVESTMENT MANAGEMENT INC | 2,525,857 | $8,676,000 | 1.14% |
| Eversept Partners, LP | 1,143,211 | $3,926,930 | 0.87% |
| DAFNA Capital Management LLC | 749,051 | $2,573,000 | 0.84% |
| KNOTT DAVID M | 397,361 | $1,365,000 | 0.80% |
| Parkman Healthcare Partners LLC | 800,740 | $2,751,000 | 0.73% |
| ACUTA CAPITAL PARTNERS, LLC | 660,000 | $2,267,000 | 0.62% |
| Formidable Asset Management, LLC | 578,200 | $1,949,000 | 0.57% |